David Linetsky Phreesia, Inc. (PHR) insider trading activity

David Linetsky is SVP, Life Sciences of Phreesia, Inc.. Currently has a direct ownership of 203,318 shares of PHR, which is worth approximately $4.8 Million. The most recent transaction as insider was on Sep 10, 2024, when has been sold 1,716 shares (Common Stock) at a price of $23.25 per share, resulting in proceeds of $39,897. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 203K

0.35% 3M change

6.35% 12M change

Total Value Held $4.8 Million

David Linetsky Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2024	SELL Open market or private sale	$39,897 $23.25 p/Share	1,716 Reduced 0.84%	203,318 Common Stock
Sep 06 2024	BUY Grant, award, or other acquisition	-	2,816 Added 1.35%	205,034 Common Stock
Jul 16 2024	SELL Open market or private sale	$43,206 $23.74 p/Share	1,820 Reduced 0.89%	202,218 Common Stock
Apr 15 2024	SELL Open market or private sale	$50,566 $22.86 p/Share	2,212 Reduced 1.07%	204,038 Common Stock
Apr 08 2024	SELL Open market or private sale	$89,317 $22.82 p/Share	3,914 Reduced 1.86%	206,250 Common Stock
Apr 05 2024	BUY Grant, award, or other acquisition	-	6,105 Added 2.82%	210,164 Common Stock
Jan 17 2024	SELL Open market or private sale	$739,495 $24.12 p/Share	30,659 Reduced 13.06%	204,059 Common Stock
Jan 16 2024	SELL Open market or private sale	$56,906 $24.55 p/Share	2,318 Reduced 0.98%	234,718 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	22,000 Added 8.49%	237,036 Common Stock
Oct 16 2023	SELL Open market or private sale	$34,515 $16.61 p/Share	2,078 Reduced 0.96%	215,036 Common Stock
Sep 13 2023	SELL Open market or private sale	$42,724 $20.75 p/Share	2,059 Reduced 0.94%	217,114 Common Stock
Sep 12 2023	BUY Exercise of conversion of derivative security	$68,984 $5.82 p/Share	11,853 Added 5.13%	219,173 Common Stock
Sep 12 2023	BUY Grant, award, or other acquisition	-	3,279 Added 1.56%	207,320 Common Stock
Jul 14 2023	SELL Payment of exercise price or tax liability	$65,686 $33.72 p/Share	1,948 Reduced 0.95%	204,041 Common Stock
Apr 14 2023	SELL Payment of exercise price or tax liability	$61,634 $31.64 p/Share	1,948 Reduced 0.94%	205,989 Common Stock
Apr 10 2023	SELL Payment of exercise price or tax liability	$54,270 $30.15 p/Share	1,800 Reduced 0.86%	207,937 Common Stock
Apr 10 2023	BUY Grant, award, or other acquisition	-	4,248 Added 1.99%	209,737 Common Stock
Feb 02 2023	SELL Open market or private sale	$449,999 $39.55 p/Share	11,378 Reduced 5.25%	205,489 Common Stock
Jan 17 2023	SELL Payment of exercise price or tax liability	$33,740 $35.0 p/Share	964 Reduced 0.44%	216,867 Common Stock
Jan 15 2023	SELL Payment of exercise price or tax liability	$398,220 $35.41 p/Share	11,246 Reduced 6.12%	172,647 Common Stock
Jan 15 2023	BUY Grant, award, or other acquisition	-	45,184 Added 17.18%	217,831 Common Stock
Jan 14 2023	SELL Payment of exercise price or tax liability	$56,372 $35.41 p/Share	1,592 Reduced 0.86%	183,893 Common Stock
Dec 13 2022	SELL Open market or private sale	$393,757 $34.61 p/Share	11,377 Reduced 5.78%	185,485 Common Stock
Dec 09 2022	SELL Open market or private sale	$798,937 $29.77 p/Share	26,837 Reduced 12.0%	196,862 Common Stock
Oct 14 2022	SELL Payment of exercise price or tax liability	$39,318 $22.48 p/Share	1,749 Reduced 0.78%	223,699 Common Stock

David Linetsky

SVP, Life Sciences

Raleigh, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHR shares.

Notify only if

Value

Insider Trading

Get notified when an Phreesia, Inc. insider buys or sells PHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Phreesia, Inc.

Track Activities on PHR

Account